In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira — one of the world’s best-selling medicines — at a steep discount, and will work with Mark Cuban’s generic drug company to make the medicine available directly to consumers for even less.
Specifically, the Coherus medicine will carry a $995 list price for a carton of two autoinjectors, an 85%…
This story from statnews.com was posted on 2023-06-01 by @alpinec.